For example, using a CSF1R inhibitor (PLX3397 or BLZ945) to repolarize TAMs to the M1 type reduced tumour volume and prolonged survival time in both glioblastoma and breast cancer mouse models [54, 55]. Here, CSF1R is linked to breast cancer.